Literature DB >> 17978889

Computational studies of the binding modes of A 2A adenosine receptor antagonists.

Y Ye1, J Wei, X Dai, Q Gao.   

Abstract

A molecular docking study was performed on several structurally diverse A(2A) AR antagonists, including xanthines, and non-xanthine type antagonists to investigate their binding modes with A(2A) adenosine receptor (AR), one of the four subtypes of AR, which is currently of great interest as a target for therapeutic intervention, in particular for Parkinson's disease. The high-affinity binding site was found to be a hydrophobic pocket with the involvement of hydrogen bonding interactions as well as pi-pi stacking interactions with the ligands. The detailed binding modes for both xanthine and non-xanthine type A(2A) antagonists were compared and the essential features were extracted and converted to database searchable queries for virtual screening study of novel A(2A) AR antagonists. Findings from this study are helpful for elucidating the binding pattern of A(2A) AR antagonists and for the design of novel active ligands.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17978889      PMCID: PMC7087644          DOI: 10.1007/s00726-007-0604-2

Source DB:  PubMed          Journal:  Amino Acids        ISSN: 0939-4451            Impact factor:   3.520


  53 in total

Review 1.  Structural bioinformatics and its impact to biomedical science.

Authors:  Kuo-Chen Chou
Journal:  Curr Med Chem       Date:  2004-08       Impact factor: 4.530

2.  Photoisomerization of a potent and selective adenosine A2 antagonist, (E)-1,3-Dipropyl-8-(3,4-dimethoxystyryl)-7-methylxanthine.

Authors:  Y Nonaka; J Shimada; H Nonaka; N Koike; N Aoki; H Kobayashi; H Kase; K Yamaguchi; F Suzuki
Journal:  J Med Chem       Date:  1993-11-12       Impact factor: 7.446

3.  A model of the complex between cyclin-dependent kinase 5 and the activation domain of neuronal Cdk5 activator.

Authors:  K C Chou; K D Watenpaugh; R L Heinrikson
Journal:  Biochem Biophys Res Commun       Date:  1999-06-07       Impact factor: 3.575

4.  Role of cyclic nucleotides in vasodilations of the rat thoracic aorta induced by adenosine analogues.

Authors:  S M Hourani; K Boon; H M Fooks; D J Prentice
Journal:  Br J Pharmacol       Date:  2001-07       Impact factor: 8.739

Review 5.  KW-6002 (Kyowa Hakko Kogyo).

Authors:  L J Knutsen; S M Weiss
Journal:  Curr Opin Investig Drugs       Date:  2001-05

6.  3D structure modeling of cytochrome P450 2C19 and its implication for personalized drug design.

Authors:  Jing-Fang Wang; Dong-Qing Wei; Lin Li; Si-Yuan Zheng; Yi-Xue Li; Kuo-Chen Chou
Journal:  Biochem Biophys Res Commun       Date:  2007-02-08       Impact factor: 3.575

Review 7.  Techniques: Recent developments in computer-aided engineering of GPCR ligands using the human adenosine A3 receptor as an example.

Authors:  Stefano Moro; Giampiero Spalluto; Kenneth A Jacobson
Journal:  Trends Pharmacol Sci       Date:  2005-01       Impact factor: 14.819

8.  8-(Sulfostyryl)xanthines: water-soluble A2A-selective adenosine receptor antagonists.

Authors:  C E Müller; J Sandoval-Ramírez; U Schobert; U Geis; W Frobenius; K N Klotz
Journal:  Bioorg Med Chem       Date:  1998-06       Impact factor: 3.641

9.  Modelling extracellular domains of GABA-A receptors: subtypes 1, 2, 3, and 5.

Authors:  Kuo-Chen Chou
Journal:  Biochem Biophys Res Commun       Date:  2004-04-09       Impact factor: 3.575

10.  Virtual screening for finding natural inhibitor against cathepsin-L for SARS therapy.

Authors:  S-Q Wang; Q-S Du; K Zhao; A-X Li; D-Q Wei; K-C Chou
Journal:  Amino Acids       Date:  2006-09-29       Impact factor: 3.520

View more
  1 in total

1.  In Silico Studies Targeting G-protein Coupled Receptors for Drug Research Against Parkinson's Disease.

Authors:  Agostinho Lemos; Rita Melo; Antonio Jose Preto; Jose Guilherme Almeida; Irina Sousa Moreira; Maria Natalia Dias Soeiro Cordeiro
Journal:  Curr Neuropharmacol       Date:  2018       Impact factor: 7.363

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.